Optimizing Frontline Therapy in Ovarian Cancer Using PARP Inhibitors: A Video Roundtable

Download this slideset from an expert roundtable discussion covering the latest insights on PARP inhibitors for frontline maintenance treatment in patients with ovarian cancer.

This educational activity is intended for clinicians practicing medicine outside of the United States.

Nicoletta Colombo, MD
Thomas J. Herzog, MD
Ignace Vergote, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 4.68 MB
Released: May 21, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This educational activity is supported by an educational grant from
GlaxoSmithKline

Related Content

Experts provide their thoughts on key data in breast and gynecologic cancers from the 2022 ASCO Annual Meeting, from Clinical Care Options (CCO)

Joyce O'Shaughnessy, MD Angeles Alvarez Secord, MD, MHSc Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: August 17, 2022 Expired: August 16, 2023

Commentary on novel agents for platinum-resistant ovarian cancer, from Clinical Care Options (CCO)

person default Kathleen Moore, MD Released: August 11, 2022

Interactive online tool with expert management recommendations for selecting therapy for women with ovarian cancer, from Clinical Care Options (CCO)

Robert L. Coleman, MD, FACOG, FACS Linda R. Duska, MD, MPH Thomas J. Herzog, MD person default Kathleen Moore, MD person default David O'Malley, MD Released: August 5, 2022

Gain important nursing insights on the management of patients with gynecologic cancers in this program from Clinical Care Options (CCO)

person default Courtney Arn, CNP Released: August 2, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings